News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Glenmark Pharmaceuticals, Sanofi (France) in $345 Million Drug-Licensing Pact
May 3, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WSJ -- India's Glenmark Pharmaceuticals Ltd. said Monday it has agreed to license out development and commercialization rights of a painkiller it is developing to France's Sanofi-Aventis S.A.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Asia
Sanofi
MORE ON THIS TOPIC
Funding
Backed by NVIDIA and Anthropic, Basecamp bags $140M to advance AI-designed drugs
September 24, 2026
·
1 min read
·
Tristan Manalac
Deals
Roche inks up to $2B deal with Atavistik for new cardiometabolic drugs
September 24, 2026
·
2 min read
·
Gabrielle Masson
China
Lilly sets aside up to $3.25B to tackle critical unmet need targets with InnoCare
September 24, 2026
·
1 min read
·
Tristan Manalac
Venture capital
AI drug hunter Enveda raises $311M for late-stage obesity, inflammatory disease push
September 23, 2026
·
1 min read
·
Annalee Armstrong
